Salmonella and Campylobacter are becoming increasingly resistant to ciprofloxacin, one of the antibiotics of choice for treating infections caused by these bacteria.” EFSA 3 Mar 2020

more information

Vaccines are efficient tools to prevent bacterial infections and thus can reduce efficiently the use of antibiotics.
Based on a novel glycoengineering platform, we develop vaccines with a current focus on farming animals. Our first projects target Campylobacter colonization in chicken and Actinobacillus pleuropneumonie infection in pigs.

Salmonella and Campylobacter are becoming increasingly resistant to ciprofloxacin, one of the antibiotics of choice for treating infections caused by these bacteria.” EFSA 3 Mar 2020

more information

Vaccines are efficient tools to prevent bacterial infections and thus can reduce efficiently the use of antibiotics.
Based on a novel glycoengineering platform, we develop vaccines with a current focus on farming animals. Our first projects target Campylobacter colonization in chicken and Actinobacillus pleuropneumonie infection in pigs.

Malcisbo AG, Wagistrasse 27a, CH-8952 Schlieren, Phone: +41 44 732 22 00, This email address is being protected from spambots. You need JavaScript enabled to view it.